| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Odonate Therapeutics, Inc. | Director, 10%+ Owner | Common Stock | 4.61M | $7.23M | $1.57 | 19 Nov 2021 | Indirect |
| Odonate Therapeutics, Inc. | Director, 10%+ Owner | Common Stock | 446K | $699K | $1.57 | 19 Nov 2021 | Direct |
| Rain Oncology Inc. | Director | Common Stock, par value $0.001 per share | 0 | $0 | $1.21 | 26 Jan 2024 | Direct |
| Tango Therapeutics, Inc. | Other* | Stock Option (Right to Buy) | 65K | 03 Sep 2024 | Direct | ||
| iTeos Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 24.2K | 11 Jun 2024 | Direct | ||
| Mirati Therapeutics, Inc. | Director | Common Stock | 0 | $59.02 | 23 Jan 2024 | Direct | |
| Mirati Therapeutics, Inc. | Director | Option to Purchase Common Stock | 0 | 23 Jan 2024 | Direct | ||
| Rain Oncology Inc. | Director | Stock Option (Right to Buy) | 0 | 26 Jan 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TNGX | Tango Therapeutics, Inc. | 03 Sep 2024 | 1 | $0 | 4 | Other* | 05 Sep 2024, 21:01 |
| ITOS | iTeos Therapeutics, Inc. | 11 Jun 2024 | 1 | $0 | 4 | Director | 13 Jun 2024, 20:00 |
| RAIN | Rain Oncology Inc. | 26 Jan 2024 | 3 | $0 | 4 | Director | 26 Jan 2024, 16:41 |
| MRTX | Mirati Therapeutics, Inc. | 23 Jan 2024 | 6 | $0 | 4 | Director | 23 Jan 2024, 20:38 |
| MRTX | Mirati Therapeutics, Inc. | 29 Dec 2023 | 1 | $400K | 4 | Director | 03 Jan 2024, 20:50 |
| RAIN | Rain Oncology Inc. | 09 Aug 2023 | 1 | $0 | 4 | Director | 11 Aug 2023, 21:05 |
| ITOS | iTeos Therapeutics, Inc. | 13 Jun 2023 | 1 | $0 | 4 | Director | 15 Jun 2023, 19:52 |
| TNGX | Tango Therapeutics, Inc. | 06 Jun 2023 | 2 | $0 | 4 | Director | 08 Jun 2023, 21:32 |
| MRTX | Mirati Therapeutics, Inc. | 20 Jan 2023 | 2 | $0 | 4 | Director, 10%+ Owner | 24 Jan 2023, 15:20 |
| RAIN | Rain Therapeutics Inc. | 04 Nov 2022 | 2 | $8M | 4 | Director | 08 Nov 2022, 15:30 |
| ITOS | iTeos Therapeutics, Inc. | 09 Jun 2022 | 1 | $0 | 4 | Director | 10 Jun 2022, 19:47 |
| TNGX | Tango Therapeutics, Inc. | 08 Jun 2022 | 1 | $0 | 4 | Director | 28 Jun 2022, 16:30 |
| RAIN | Rain Therapeutics Inc. | 01 Jun 2022 | 1 | $0 | 4 | Director | 19 Aug 2022, 17:40 |
| ITOS | iTeos Therapeutics, Inc. | 09 May 2022 | 6 | -$13.9M | 4 | Director | 11 May 2022, 21:15 |
| ITOS | iTeos Therapeutics, Inc. | 28 Apr 2022 | 5 | -$10.2M | 4 | Director | 02 May 2022, 21:15 |
| ITOS | iTeos Therapeutics, Inc. | 22 Mar 2022 | 4 | $1.63M | 4 | Director | 24 Mar 2022, 21:00 |
| MRTX | Mirati Therapeutics, Inc. | 14 Jan 2022 | 2 | $0 | 4 | Director, 10%+ Owner | 18 Jan 2022, 17:17 |
| ODT | Odonate Therapeutics, Inc. | 17 Nov 2021 | 5 | -$2.5M | 4 | Director, 10%+ Owner | 19 Nov 2021, 18:22 |
| ITOS | iTeos Therapeutics, Inc. | 17 Jun 2021 | 1 | $0 | 4 | Director | 21 Jun 2021, 20:17 |